NAFLD
Showing 1 - 25 of 1,175
NAFLD in Patient of Hypothyroidism
Not yet recruiting
- NAFLD
- (no location specified)
Apr 2, 2023
Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -
Completed
- Nonalcoholic Fatty Liver Disease
- Anti-human CCL24 monoclonal antibody (CM-101) - Part One
- +3 more
-
Jerusalem, IsraelHadassah University Hospital - Ein Kerem
Sep 13, 2023
NAFLD, Diabetes Trial in Durham (behavioral, drug, diagnostic test)
Not yet recruiting
- NAFLD
- Diabetes Mellitus
- NAFLD Education
- +3 more
-
Durham, North CarolinaDuke University Healthcare System
Apr 25, 2023
Relation Between NAFLD and BM DENSITY
Not yet recruiting
- NAFLD
- Osteoporosis
- Fibroscan
- (no location specified)
Sep 14, 2023
NAFLD Trial (Placebo, 2 cap.LivPhcD/per day, 4 cap.LivPhcD/per day)
Not yet recruiting
- NAFLD
- Placebo
- +3 more
- (no location specified)
Jun 25, 2023
Obesity, NAFLD Trial (Usual Care Control Group, Moderate-intensity Exercise Intervention, Vigorous-intensity Exercise
Not yet recruiting
- Obesity
- NAFLD
- Usual Care Control Group
- +2 more
- (no location specified)
Nov 3, 2023
PCOS, NAFLD, NASH Trial in San Francisco, Durham
Recruiting
- PCOS
- +2 more
-
San Francisco, California
- +1 more
Nov 3, 2023
Non-Alcoholic Fatty Liver Disease (NAFLD) Trial in Jakarta Pusat (Proliverenol, Placebo caplets of Proliverenol)
Recruiting
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- Proliverenol
- Placebo caplets of Proliverenol
-
Jakarta Pusat, Jakarta, IndonesiaDivision of Hepatology, Dr. Cipto Mangunkusumo Hospital
Nov 7, 2023
Steatohepatitis, Nonalcoholic, Steatosis, Liver Diseases Trial in Curitiba (NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER
Active, not recruiting
- Steatohepatitis, Nonalcoholic
- +3 more
- NUTRITIONAL EDUCATIONAL INTERVENTION IN FATTY LIVER DISEASE NON-ALCOHOLIC (NAFLD).
-
Curitiba, Parana, BrazilHospital de Clínicas da Universidade Federal do Paraná
Jul 17, 2023
NAFLD Trial (homocysteine (Hcy) lowering supplements)
Not yet recruiting
- NAFLD
- homocysteine (Hcy) lowering supplements
- (no location specified)
Jan 31, 2023
NAFLD Trial in Cairo (Control Test)
Completed
- NAFLD
- Control Test
-
Cairo, EgyptAin Shams University
Oct 5, 2023
Non-Alcoholic Fatty Liver Disease Trial (Standard Soy Milk, 2% Fat Cow's Milk)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Standard Soy Milk
- 2% Fat Cow's Milk
- (no location specified)
Nov 9, 2023
NAFLD, PCOS Trial in San Francisco (Bicalutamide 50 mg, Placebo)
Not yet recruiting
- NAFLD
- PCOS
- Bicalutamide 50 mg
- Placebo
-
San Francisco, CaliforniaUniversity of California San Francisco
Aug 4, 2023
NASH, NAFLD Trial in Hangzhou (GH509, Placebo)
Recruiting
- NASH
- NAFLD
- GH509
- Placebo
-
Hangzhou, Zhejiang, ChinaThe Affiliated Hospital of Hangzhou Normal University
Mar 26, 2023
NAFLD Trial (Diet and exercise, NAC with diet and exercise)
Not yet recruiting
- NAFLD
- Diet and exercise
- NAC with diet and exercise
- (no location specified)
Oct 26, 2022
NAFLD, Non-alcoholic Fatty Liver Disease Trial in Sulaymaniyah (Beetroot juice, , Mediterranean diet alone (MeD))
Completed
- NAFLD, Non-alcoholic Fatty Liver Disease
- Beetroot juice
- +3 more
-
Sulaymaniyah, Sulaimanyah, IraqHawal
Jun 8, 2023
NAFLD Trial in Prague (Cognitive behavioral therapy)
Not yet recruiting
- NAFLD
- Cognitive behavioral therapy
-
Prague, CzechiaGeneral University Hospital
Apr 17, 2023
NAFLD Trial in Tucson (NAFLD-specific weight loss intervention, Wait-list control)
Not yet recruiting
- NAFLD
- NAFLD-specific weight loss intervention
- Wait-list control
-
Tucson, ArizonaUniversity of Arizona Collaboratory for Metabolic Disease Preven
Oct 7, 2022
Non-Alcoholic Fatty Liver Disease Trial in Genk (Coach, App, Standard of care)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Coach
- +2 more
-
Genk, Limburg, BelgiumZiekenhuis Oost-Limburg
Mar 28, 2023
Non-Alcoholic Fatty Liver Disease Trial in Kurdistan (Multiviamins and minerals, Placebo)
Completed
- Non-Alcoholic Fatty Liver Disease
- Multiviamins and minerals
- Placebo
-
Kurdistan, Kalar, IraqHawal Fateh
Jun 8, 2023
Type 2 Diabetes, NAFLD Trial (Drinking powder supplement)
Not yet recruiting
- Type 2 Diabetes
- NAFLD
- Drinking powder supplement
- (no location specified)
Dec 8, 2022
Non-Alcoholic Fatty Liver Disease, Type2diabetes Trial in Karachi (Empagliflozin 10 MG, Pioglitazone 15mg, Metformin)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Type2diabetes
- Empagliflozin 10 MG
- +2 more
-
Karachi, Sindh, PakistanMedical ICU, Jinnah Postgraduate Medical Centre
Jul 11, 2023
Fibrosis, Liver, Type 2 Diabetes in Obese, Non-Alcoholic Fatty Liver Disease Trial in La Jolla (Semaglutide, Placebo)
Recruiting
- Fibrosis, Liver
- +2 more
- Semaglutide
- Placebo
-
La Jolla, CaliforniaUniversity of California, San Diego
Aug 25, 2023
Non-alcoholic Fatty Liver Disease (NAFLD), Alcoholic Liver Disease (ALD), Liver Fibrosis Trial in France (eLIFT)
Not yet recruiting
- Non-alcoholic Fatty Liver Disease (NAFLD)
- +2 more
- eLIFT
-
Angers, France
- +5 more
Jan 26, 2023